LGM
Logos Global Management’s Astria Therapeutics ATXS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.75M | Buy |
700,000
+200,000
| +40% | +$1.07M | 0.42% | 39 |
|
2025
Q1 | $2.67M | Hold |
500,000
| – | – | 0.47% | 32 |
|
2024
Q4 | $4.47M | Hold |
500,000
| – | – | 0.52% | 37 |
|
2024
Q3 | $5.51M | Hold |
500,000
| – | – | 0.59% | 37 |
|
2024
Q2 | $4.55M | Sell |
500,000
-744,960
| -60% | -$6.78M | 0.37% | 40 |
|
2024
Q1 | $17.5M | Buy |
1,244,960
+700,000
| +128% | +$9.85M | 1.42% | 20 |
|
2023
Q4 | $4.19M | Hold |
544,960
| – | – | 0.39% | 40 |
|
2023
Q3 | $4.07M | Hold |
544,960
| – | – | 0.54% | 39 |
|
2023
Q2 | $4.54M | Sell |
544,960
-500,000
| -48% | -$4.17M | 0.62% | 42 |
|
2023
Q1 | $13.9M | Buy |
1,044,960
+180,000
| +21% | +$2.39M | 1.99% | 21 |
|
2022
Q4 | $12.9M | Buy |
+864,960
| New | +$12.9M | 1.51% | 23 |
|
2021
Q3 | – | Sell |
-3,190,000
| Closed | -$6.73M | – | 60 |
|
2021
Q2 | $6.73M | Buy |
+3,190,000
| New | +$6.73M | 0.57% | 42 |
|